- Previous Close
997.35 - Open
995.95 - Bid --
- Ask --
- Day's Range
976.60 - 999.75 - 52 Week Range
538.65 - 1,118.00 - Volume
3,754,632 - Avg. Volume
1,741,877 - Market Cap (intraday)
966.834B - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
91.70 - EPS (TTM)
10.84 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield 1.50 (0.15%)
- Ex-Dividend Date Aug 23, 2024
- 1y Target Est
--
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
www.maxhealthcare.in19,500
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: MAXHEALTH.NS
View MorePerformance Overview: MAXHEALTH.NS
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MAXHEALTH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MAXHEALTH.NS
View MoreValuation Measures
Market Cap
967.56B
Enterprise Value
972.84B
Trailing P/E
92.11
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
17.43
Price/Book (mrq)
11.50
Enterprise Value/Revenue
18.32
Enterprise Value/EBITDA
58.79
Financial Highlights
Profitability and Income Statement
Profit Margin
18.61%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
56.64B
Net Income Avi to Common (ttm)
10.54B
Diluted EPS (ttm)
10.84
Balance Sheet and Cash Flow
Total Cash (mrq)
10.99B
Total Debt/Equity (mrq)
15.45%
Levered Free Cash Flow (ttm)
--